NCT02498665.
Trial name or title | A phase I clinical study of DSP‐7888 dosing emulsion in adult patients with advanced malignancies |
Methods | Non‐randomised phase I |
Participants | 96 participants with advanced malignancies |
Interventions | WT1 protein‐derived peptide vaccine (DSP‐7888) |
Outcomes | DLT Survival Immune response |
Starting date | November 2015 |
Contact information | |
Notes | Recruiting, April 2018 |